Title:
【発明の名称】プリンL―ヌクレオシド類およびその用途
Document Type and Number:
Japanese Patent JP2001524936
Kind Code:
A
Abstract:
Novel purine L-nucleoside compounds are disclosed, in which both the purine rings and the sugar are either modified, functionalized, or both. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Th1 and Th2.
Inventors:
One, Cowanee
Tam, robert
Abelto, Develon
Tam, robert
Abelto, Develon
Application Number:
JP51847598A
Publication Date:
December 04, 2001
Filing Date:
October 15, 1997
Export Citation:
Assignee:
ICN Pharmacy Youthicals Incorporated
International Classes:
A61K31/519; A61K31/52; A61K31/522; A61K31/70; A61K31/7042; A61K31/7052; A61K31/7056; A61K31/706; A61K31/7064; A61K31/7072; A61K31/7076; A61K31/708; A61K31/7115; A61K45/06; A61P1/04; A61P3/10; A61P11/06; A61P17/00; A61P17/06; C07H15/20; A61P19/02; A61P19/06; A61P29/00; A61P31/00; A61P33/00; A61P35/00; A61P37/02; A61P37/06; A61P43/00; C07H19/02; C07H19/04; C07H19/14; C07H19/16; C07H19/23; C07H19/24; (IPC1-7): C07H19/16; A61K31/706; A61K31/7072; A61K31/708; A61P1/04; A61P3/10; A61P11/06; A61P17/00; A61P17/06; A61P19/02; A61P19/06; A61P31/00; A61P33/00; A61P35/00; A61P37/06; C07H19/02; C07H19/14; C07H19/23; C07H19/24
Attorney, Agent or Firm:
Yoshio Kawaguchi (2 outside)